CD73 rather than CD39 is mainly involved in controlling purinergic signaling in calcified aortic valve disease. / Kudryavtsev, Igor V.; Serebriakova, Mariia; Zhiduleva, Ekaterine; Murtazalieva, Patimat; Titov, Vladislav; Malashicheva, Anna; Shishkova, Anastasya; Semenova, Daria; Irtyuga, Olga; Isakov, Dmitry; Moiseeva, Olga; Golovkin, Alexey.
In: Frontiers in Genetics, Vol. 10, 604, 25.07.2019.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - CD73 rather than CD39 is mainly involved in controlling purinergic signaling in calcified aortic valve disease
AU - Kudryavtsev, Igor V.
AU - Serebriakova, Mariia
AU - Zhiduleva, Ekaterine
AU - Murtazalieva, Patimat
AU - Titov, Vladislav
AU - Malashicheva, Anna
AU - Shishkova, Anastasya
AU - Semenova, Daria
AU - Irtyuga, Olga
AU - Isakov, Dmitry
AU - Moiseeva, Olga
AU - Golovkin, Alexey
N1 - Kudryavtsev I, Serebriakova M, Zhiduleva E, Murtazalieva P, Titov V, Malashicheva A, Shishkova A, Semenova D, Irtyuga O, Isakov D, Mitrofanova L, Moiseeva O and Golovkin A (2019) CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease. Front. Genet. 10:604. doi: 10.3389/fgene.2019.00604
PY - 2019/7/25
Y1 - 2019/7/25
N2 - The study aimed to compare composition of peripheral blood T-cell subsets and assess their surface expression of CD39 and CD73 ectonucleotidases in patients with severe and moderate aortic stenosis (AS) as well as to evaluate involvement of T-cell-mediated immune processes in valve calcification. The study was performed with 38 patients suffering from severe calcified aortic stenosis (SAS), 33 patients with MAS, and 30 apparently healthy volunteers (HVs). The relative distribution and percentage of T-cell subsets expressing CD39 and CD73 were evaluated by flow cytometry. T helper (Th) and cytotoxic T-cell subsets (Tcyt) were identified by using CD3, CD4, and CD8 antibodies. Regulatory T cells (Tregs) were characterized by the expression of CD3, CD4, and high IL-2R alpha chain (CD25high) levels. CD45R0 and CD62L were used to assess differentiation stage of Th, Tcyt, and Treg subsets. It was found that MAS and SAS patients differed in terms of relative distribution of Tcyt and absolute number of Treg. Moreover, the absolute number of Tcyt and terminally differentiated CD45RA-positive effector T-cells (TEMRA) subset was significantly higher in SAS vs. MAS patients and HVs. However, the absolute and relative number of naïve Th and the absolute number of Treg were significantly higher in MAS vs. SAS patients; the relative number of naïve Tregs was significantly (p < 0.01) decreased in SAS patients. It was shown that CD73 expression was significantly higher in SAS vs. MAS patients noted in all EM, CM, TEMRA, and naïve Th cell subsets. However, only the latter were significantly increased (p = 0.003) in patients compared with HVs. SAS vs. MAS patients were noted to have significantly higher percentage of CD73+ EM Tcyt (p = 0.006) and CD73+ CM Tcyt (p = 0.002). The expression of CD73 in patients significantly differed in all three Treg populations such as EM (p = 0.049), CM (p = 0.044), and naïve (p < 0.001). No significant differences in CD39 expression level was found in MAS and SAS patients compared with the HV group. Overall, the data obtained demonstrated that purinergic signaling was involved in the pathogenesis of aortic stenosis and calcification potentially acting via various cell types, wherein among enzymes, degrading extracellular ATP CD73 rather than CD39 played a prominent role.
AB - The study aimed to compare composition of peripheral blood T-cell subsets and assess their surface expression of CD39 and CD73 ectonucleotidases in patients with severe and moderate aortic stenosis (AS) as well as to evaluate involvement of T-cell-mediated immune processes in valve calcification. The study was performed with 38 patients suffering from severe calcified aortic stenosis (SAS), 33 patients with MAS, and 30 apparently healthy volunteers (HVs). The relative distribution and percentage of T-cell subsets expressing CD39 and CD73 were evaluated by flow cytometry. T helper (Th) and cytotoxic T-cell subsets (Tcyt) were identified by using CD3, CD4, and CD8 antibodies. Regulatory T cells (Tregs) were characterized by the expression of CD3, CD4, and high IL-2R alpha chain (CD25high) levels. CD45R0 and CD62L were used to assess differentiation stage of Th, Tcyt, and Treg subsets. It was found that MAS and SAS patients differed in terms of relative distribution of Tcyt and absolute number of Treg. Moreover, the absolute number of Tcyt and terminally differentiated CD45RA-positive effector T-cells (TEMRA) subset was significantly higher in SAS vs. MAS patients and HVs. However, the absolute and relative number of naïve Th and the absolute number of Treg were significantly higher in MAS vs. SAS patients; the relative number of naïve Tregs was significantly (p < 0.01) decreased in SAS patients. It was shown that CD73 expression was significantly higher in SAS vs. MAS patients noted in all EM, CM, TEMRA, and naïve Th cell subsets. However, only the latter were significantly increased (p = 0.003) in patients compared with HVs. SAS vs. MAS patients were noted to have significantly higher percentage of CD73+ EM Tcyt (p = 0.006) and CD73+ CM Tcyt (p = 0.002). The expression of CD73 in patients significantly differed in all three Treg populations such as EM (p = 0.049), CM (p = 0.044), and naïve (p < 0.001). No significant differences in CD39 expression level was found in MAS and SAS patients compared with the HV group. Overall, the data obtained demonstrated that purinergic signaling was involved in the pathogenesis of aortic stenosis and calcification potentially acting via various cell types, wherein among enzymes, degrading extracellular ATP CD73 rather than CD39 played a prominent role.
KW - Calcification
KW - Calcified aortic stenosis
KW - CD39 and CD73 expression
KW - Purinergic signaling
KW - T-Cells (or lymphocytes)
KW - calcified aortic stenos T-cells (or lymphocytes)
KW - EXTRACELLULAR ATP
KW - purinergic signaling
KW - ACTIVATION
KW - ADENOSINE
KW - RECEPTOR
KW - TREG CELLS
KW - REGULATORY T-CELLS
KW - TRIPHOSPHATE
KW - GENERATION
KW - calcification
KW - DIFFERENTIATION
KW - EXPRESSION
UR - http://www.scopus.com/inward/record.url?scp=85069051372&partnerID=8YFLogxK
U2 - 10.3389/fgene.2019.00604
DO - 10.3389/fgene.2019.00604
M3 - Comment/debate
AN - SCOPUS:85069051372
VL - 10
JO - Frontiers in Genetics
JF - Frontiers in Genetics
SN - 1664-8021
M1 - 604
ER -
ID: 45918334